Potential prognostic value of rheumatoid factor in anti-aquaporin 4-immunoglobin G-positive neuromyelitis optica spectrum disorders
Hye Lim Lee(Korea University Medical Center), Eun Bin Cho(Changwon National University), Ha Young Shin(Yonsei University), Seol‐Hee Baek(Korea University Medical Center), Soon-Young Hwang(Korea University), Jin Myoung Seok(Samsung Medical Center), Ohyun Kwon(Eulji University), Byung‐Jo Kim(Korea University), So‐Young Huh(Kosin University Gospel Hospital), Jong Kuk Kim(Dong-A University), Joong‐Yang Cho(Inje University Ilsan Paik Hospital), Jeeyoung Oh(Université Paris-Sud), Byeol‐A Yoon(Kyungpook National University Hospital), Young‐Min Lim(Ulsan College), Hung Youl Seok(Keimyung University), Ho‐Jin Kim(National Cancer Center), Sooyoung Kim(Chungnam National University), Sang‐Soo Lee(Chungbuk National University), Ju‐Hong Min(Samsung Medical Center), Byoung Joon Kim(Samsung Medical Center), Sa-Yoon Kang(Soonchunhyang University)
Cited by 2
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
A New Subtype Classification of Ischemic Stroke Based on Treatment and Etiologic Mechanism
|European Neurology|2006|121
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
|Multiple Sclerosis Journal|2013|84
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea
|Multiple Sclerosis Journal|2017|82